Repligen Corporation (RGEN)
NASDAQ·Healthcare·Medical - Instruments & Supplies
$179.50
+0.69%
Mkt Cap $11.23B
Analyst Ratings
Buy
8
Hold
1
Sell
0
Price Target (25 analysts)
$162.43
Range $142.00 – $225.00
Implied Upside
-9.5%
Consensus $162.43 vs current $179.50